Article info

Download PDFPDF

Nuclear factor erythroid 2-related factors 1 and 2 are able to define the worst prognosis group among high-risk diffuse large B cell lymphomas treated with R-CHOEP

Authors

  1. Correspondence to Dr Esa Kari, Cancer Research and Translational Medicine Research Unit, Oulun Yliopisto Laaketieteellisen tiedekunta, Oulu 90220, Finland; esa.kari{at}student.oulu.fi
View Full Text

Citation

Kari E, Teppo H, Haapasaari K, et al
Nuclear factor erythroid 2-related factors 1 and 2 are able to define the worst prognosis group among high-risk diffuse large B cell lymphomas treated with R-CHOEP

Publication history

  • Received November 2, 2018
  • Revised January 8, 2019
  • Accepted January 16, 2019
  • First published February 12, 2019.
Online issue publication 
March 20, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.